Marked elevation of vascular endothelial growth factor and basic fibroblast growth factor in pericardial fluid of patients with angina pectoris

被引:21
作者
Fujita M. [1 ,5 ]
Ikemoto M. [1 ]
Tanaka T. [2 ]
Tamaki S.-I. [2 ]
Yamazato A. [2 ]
Sawamura T. [3 ]
Hasegawa K. [4 ]
Kihara Y. [4 ]
Nohara R. [4 ]
Sasayama S. [4 ]
机构
[1] College of Medical Technology, Kyoto University
[2] Takeda Hospital, Kyoto University, Graduate School of Medicine
[3] Department of Pharmacology, Kyoto University, Graduate School of Medicine
[4] Dept. of Cardiovascular Medicine, Kyoto University, Graduate School of Medicine
[5] College of Medical Technology, Kyoto University, Shogoin, Sakyo-ku, Kyoto 606-01
基金
日本学术振兴会;
关键词
Angiogenesis; Collateral circulation; Coronary artery bypass graft surgery; Stable angina; Unstable angina;
D O I
10.1023/A:1009062712441
中图分类号
学科分类号
摘要
Although we reported that basic fibroblast growth factor (bFGF) levels in pericardial fluid of patients with unstable angina are apparently increased, it was unclear whether vascular endothelial growth factor (VEGF) is also increased in patients with myocardial ischemia. Using an enzyme-linked immunosorbent assay, we measured the concentrations of VEGF and bFGF in pericardial fluid of 51 patients with open heart surgery. Patients were divided into group A (n = 10) with class III unstable angina (Braunwald's classification), group B (n = 24) with class I or II unstable angina or stable angina and group C (n = 17) with non-ischemic heart disease. The VEGF level in pericardial fluid in group A was 83 ± 7 pg/ml, being significantly (p < 0.001) higher than the 27 ± 3 pg/ml in group B and the 28 ± 5 pg/ml in group C. The concentrations of bFGF in pericardial fluid in groups A and B were 1461 ± 579 and 1224 ± 161 pg/ml, respectively, significantly (p < 0.05) higher than the 292 ± 97 pg/ml in group C. The level of VEGF in pericardial fluid was increased only in patients with severe rest angina within 2 days before emergency coronary artery bypass graft surgery (CABG), while bFGF was increased in all patients undergoing CABG for coronary artery disease. Thus VEGF and bFGF may play important roles in mediating collateral growth in humans. [© 1998 Rapid Science Ltd.].
引用
收藏
页码:105 / 108
页数:3
相关论文
共 13 条
  • [1] Sasayama S., Fujita M., Recent insights into coronary collateral circulation, Circulation, 85, pp. 197-1204, (1992)
  • [2] Fujita M., Salutary effects of myocardial ischemia in coronary artery disease, Int J Cardiol, 52, pp. 197-202, (1995)
  • [3] Pasyk S., Schaper W., Schaper J., Pasyk K., Miskiewicz G., Steinseifer B., DNA synthesis in coronary collaterals after coronary artery occlusion in conscious dogs, Am J Physiol, 242, (1982)
  • [4] Schaper W., Ito W.D., Molecular mechanisms of coronary collateral vessel growth, Cric Res, 79, pp. 911-919, (1996)
  • [5] Fujita M., Ikemoto M., Kishishita M., Et al., Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina, Circulation, 94, pp. 610-613, (1996)
  • [6] Braunwald E., Unstable angina: A classification, Circulation, 80, pp. 410-414, (1989)
  • [7] Brogi E., Tiangen W., Namiki A., Isner J.M., Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only, Circulation, 90, pp. 649-652, (1994)
  • [8] Symons J.D., Pitsillides K.F., Longhurst J.C., Chronic reduction of myocardial ischemia does not attenuate coronary collateral development in miniswine, Circulation, 86, pp. 660-671, (1992)
  • [9] Jackson A., Tarantini F., Gamble S., Friedman S., Maciag T., The release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues, J Biol Chem, 270, pp. 33-36, (1995)
  • [10] Thompson R.W., Whalen G.F., Saunders K.B., Et al., Heparin-mediated release of fibroblast growth factor-like activity into the circulation of rabbits, Growth Factors, 3, pp. 221-229, (1990)